BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

U.S. Postal Inspection Service Awards AED Contract to Cardiac Science Corporation (CSCX)


2/10/2011 7:25:26 AM

BOTHELL, Wash., Feb. 10, 2011 /PRNewswire/ -- Cardiac Science Corporation, a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, has been awarded a contract to deploy Powerheart® AEDs at U.S. Postal Inspection Service sites across the nation. The U.S. Postal Inspection Service is the primary law enforcement arm of the United States Postal Service.

"We are proud to have been selected to protect the men and women of the Postal Inspection Service," said Dave Marver, Cardiac Science president and chief executive officer.

The Powerheart AED's RescueCoach user-paced voice prompts and CPR metronome guide rescuers confidently through a stressful rescue situation. The Powerheart AED G3 Plus delivers a shock automatically with no button to push and no human intervention. After the shock, the Powerheart AED instructs users how to perform high-quality CPR.

About Sudden Cardiac Arrest

Sudden cardiac arrest is a leading cause of death in North America, claiming more than 365,000 lives each year. It's estimated that more than 95 percent of cardiac arrest victims die before reaching the hospital. In cardiac arrest, the heart's electrical impulses fire irregularly and the heart cannot pump blood to the rest of the body. A defibrillator is the only effective therapy for sudden cardiac arrest. It provides a life-saving shock to effectively restart the heart's electrical impulses.

About Cardiac Science

Cardiac Science, a wholly owned subsidiary of Opto Circuits (India) Ltd., develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AED), electrocardiograph devices (ECG/EKG), cardiac stress treadmill and systems, PC-based diagnostic workstations, Holter monitoring systems, hospital defibrillators, vital signs monitors, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick®, HeartCentrix®, Powerheart®, and Quinton® brands, is headquartered in Bothell, Washington. With customers in almost 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.

For updates and information on worldwide defibrillation and cardiac monitoring, find us on the Cardiac Science blog at http://www.cardiacscience.com/blog, Twitter at http://twitter.com/cardiacscience, Facebook at http://budurl.com/CSonFB, and YouTube at http://budurl.com/CSonYT.

For more information, contact (media) amironova@cardiacscience.com +1.425.402.2092 | (investors) ir@optoindia.com | +91.80.2852.8088

(Logo: http://photos.prnewswire.com/prnh/20080306/AQTH510LOGO)

SOURCE Cardiac Science Corporation



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES